We report a 53-year-old man diagnosed with Richter syndrome. He was heavily pretreated and was refractory to prior therapy. He received rituximab and ibrutinib, and achieved a significant response after 1 month of therapy. Our case illustrates the importance of investigation of rituximab and ibrutinib in Richter's syndrome.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527807 | PMC |
| http://dx.doi.org/10.1002/ccr3.269 | DOI Listing |
Publication Analysis
Top Keywords
richter syndrome
8
rituximab ibrutinib
8
ibrutinib rituximab
4
rituximab induced
4
induced rapid
4
rapid response
4
response refractory
4
refractory richter
4
syndrome report
4
report 53-year-old
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!